This real-world data set shows the impact of using Tempus PRO™ to digitally measure patient treatment response.
The traditional model of activating clinical trials is widely acknowledged as inefficient. The process of establishing a clinical site, negotiating partnerships between sites and sponsors, then attempting to recruit eligible patients in nearby areas can take many months, and it becomes a burden to trial site staff, sponsors, and patients.
Read more
A hypothetical case study on how insights from the Tempus nP pharmacogenomics report can inform treatment decisions in clinical practice.
Read more
A hypothetical case study on how insights from the Tempus nP pharmacogenomics report can inform treatment decisions in clinical practice.
Read more
